Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
evolocumab (repatha) (1 trial)
acetylsalicylic acid (aspirin) (3 trials)
clopidogrel (plavix) (3 trials)
rivaroxaban (xarelto) (1 trial)
ticagrelor (brilinta) (1 trial)
Aortic Valve Stenosis (Phase 3)
Cardiovascular Diseases (Phase 3)
Coronary Artery Disease (Phase 4)
Heart Valve Diseases (Phase 3)
Thrombosis (Phase 3)
Ventricular Outflow Obstruction (Phase 3)
Trials (4 total)
Trial APIs (5 total)